Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Vig

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|January 28, 2006
The sources of parenchymal regeneration after chronic hepatocellular liver injury in micePamela Vig, Francesco P Russo, Robert J Edwards, et al.
The Journal of Pediatrics|September 12, 2022
Maralixibat Treatment Response in Alagille Syndrome is Associated with Improved Health-Related Quality of LifeBinita M Kamath, Andrea Goldstein, Robin Howard, et al.
Orphanet Journal of Rare Diseases|July 29, 2025
Use of cholic acid in Smith-Lemli-Opitz syndrome (SLOS): real-world patient outcomesEdwin Ferren, Paul R Hillman, Amy Kritzer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2026
Efficacy, Safety and Tolerability of Volixibat, an IBAT Inhibitor, in Patients With Intrahepatic Cholestasis of PregnancyCaroline Ovadia, Sophia Stone, Baha Sibai, et al.
Hepatology (Baltimore, Md.)|June 6, 2023
Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitorRonald J Sokol, Emmanuel M Gonzales, Binita M Kamath, et al.
Journal of Hepatology|November 9, 2005
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1Yves Benhamou, Vincent Thibault, Pamela Vig, et al.
Hepatology Communications|February 12, 2026
A multinational survey assessing the impact and burden of pruritus on patients with primary sclerosing cholangitisKris V Kowdley, Ricky Safer, Rachel Gomel, et al.
Hepatology (Baltimore, Md.)|September 5, 2018
Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in MiceAditya Ambade, Patrick Lowe, Karen Kodys, et al.
Frontiers in Immunology|August 31, 2018
The Critical Role of Chemokine (C-C Motif) Receptor 2-Positive Monocytes in Autoimmune CholangitisDebby Reuveni, Yael Gore, Patrick S C Leung, et al.
Hepatology Communications|March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS StudyBertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|January 28, 2006
The sources of parenchymal regeneration after chronic hepatocellular liver injury in micePamela Vig, Francesco P Russo, Robert J Edwards, et al.
The Journal of Pediatrics|September 12, 2022
Maralixibat Treatment Response in Alagille Syndrome is Associated with Improved Health-Related Quality of LifeBinita M Kamath, Andrea Goldstein, Robin Howard, et al.
Orphanet Journal of Rare Diseases|July 29, 2025
Use of cholic acid in Smith-Lemli-Opitz syndrome (SLOS): real-world patient outcomesEdwin Ferren, Paul R Hillman, Amy Kritzer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2026
Efficacy, Safety and Tolerability of Volixibat, an IBAT Inhibitor, in Patients With Intrahepatic Cholestasis of PregnancyCaroline Ovadia, Sophia Stone, Baha Sibai, et al.
Hepatology (Baltimore, Md.)|June 6, 2023
Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitorRonald J Sokol, Emmanuel M Gonzales, Binita M Kamath, et al.
Journal of Hepatology|November 9, 2005
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1Yves Benhamou, Vincent Thibault, Pamela Vig, et al.
Hepatology Communications|February 12, 2026
A multinational survey assessing the impact and burden of pruritus on patients with primary sclerosing cholangitisKris V Kowdley, Ricky Safer, Rachel Gomel, et al.
Hepatology (Baltimore, Md.)|September 5, 2018
Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in MiceAditya Ambade, Patrick Lowe, Karen Kodys, et al.
Frontiers in Immunology|August 31, 2018
The Critical Role of Chemokine (C-C Motif) Receptor 2-Positive Monocytes in Autoimmune CholangitisDebby Reuveni, Yael Gore, Patrick S C Leung, et al.
Hepatology Communications|March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS StudyBertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Pageof 3